600789.SH
鲁抗医药
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 7.19
−1.91%Margins
Gross margin
22.3%
EBITDA margin
10.7%
EBIT margin
2.5%
Net margin
1.5%
FCF margin
8.8%
1.7%
Return on equity
0.9%
Return on assets
2.0%
Return on invested capital
0.57x
Asset turnover
CNY 835.4M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026